Cargando…
Aortic valve replacement in a patient with systemic lupus erythematosus
Valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. SLE can present major challenges because of accrued organ damage, coagulation defects and complex management regim...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713678/ https://www.ncbi.nlm.nih.gov/pubmed/23878452 http://dx.doi.org/10.4103/0970-9185.111656 |
_version_ | 1782277223132168192 |
---|---|
author | Kansara, Bhuvnesh Singh, Ajmer Karlekar, Anil Mishra, Yugal K |
author_facet | Kansara, Bhuvnesh Singh, Ajmer Karlekar, Anil Mishra, Yugal K |
author_sort | Kansara, Bhuvnesh |
collection | PubMed |
description | Valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. SLE can present major challenges because of accrued organ damage, coagulation defects and complex management regimes. The peri-operative goals are to maintain strict asepsis, avoid use of nephrotoxic drugs and thereby renal insult, and to promote early ambulation post-operatively. |
format | Online Article Text |
id | pubmed-3713678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-37136782013-07-22 Aortic valve replacement in a patient with systemic lupus erythematosus Kansara, Bhuvnesh Singh, Ajmer Karlekar, Anil Mishra, Yugal K J Anaesthesiol Clin Pharmacol Case Report Valvular heart disease in systemic lupus erythematosus (SLE) is associated with substantial morbidity and mortality. Current therapy includes symptomatic measures and valve replacement. SLE can present major challenges because of accrued organ damage, coagulation defects and complex management regimes. The peri-operative goals are to maintain strict asepsis, avoid use of nephrotoxic drugs and thereby renal insult, and to promote early ambulation post-operatively. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3713678/ /pubmed/23878452 http://dx.doi.org/10.4103/0970-9185.111656 Text en Copyright: © Journal of Anaesthesiology Clinical Pharmacology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Kansara, Bhuvnesh Singh, Ajmer Karlekar, Anil Mishra, Yugal K Aortic valve replacement in a patient with systemic lupus erythematosus |
title | Aortic valve replacement in a patient with systemic lupus erythematosus |
title_full | Aortic valve replacement in a patient with systemic lupus erythematosus |
title_fullStr | Aortic valve replacement in a patient with systemic lupus erythematosus |
title_full_unstemmed | Aortic valve replacement in a patient with systemic lupus erythematosus |
title_short | Aortic valve replacement in a patient with systemic lupus erythematosus |
title_sort | aortic valve replacement in a patient with systemic lupus erythematosus |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713678/ https://www.ncbi.nlm.nih.gov/pubmed/23878452 http://dx.doi.org/10.4103/0970-9185.111656 |
work_keys_str_mv | AT kansarabhuvnesh aorticvalvereplacementinapatientwithsystemiclupuserythematosus AT singhajmer aorticvalvereplacementinapatientwithsystemiclupuserythematosus AT karlekaranil aorticvalvereplacementinapatientwithsystemiclupuserythematosus AT mishrayugalk aorticvalvereplacementinapatientwithsystemiclupuserythematosus |